First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series

BACKGROUND: Non-clear cell (ncc) metastatic renal-cell carcinoma (RCC) has dismal results with standard systemic therapies and a generally worse prognosis when compared to its clear-cell counterpart. New systemic combination therapies have emerged for metastatic RCC (mRCC), but the pivotal phase III...

Descripción completa

Detalles Bibliográficos
Autores principales: Buti, Sebastiano, Bersanelli, Melissa, Massari, Francesco, De Giorgi, Ugo, Caffo, Orazio, Aurilio, Gaetano, Basso, Umberto, Carteni, Giacomo, Caserta, Claudia, Galli, Luca, Boccardo, Francesco, Procopio, Giuseppe, Facchini, Gaetano, Fornarini, Giuseppe, Berruti, Alfredo, Fea, Elena, Naglieri, Emanuele, Petrelli, Fausto, Iacovelli, Roberto, Porta, Camillo, Mosca, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641010/
https://www.ncbi.nlm.nih.gov/pubmed/34909398
http://dx.doi.org/10.5306/wjco.v12.i11.1037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641010/
https://www.ncbi.nlm.nih.gov/pubmed/34909398
http://dx.doi.org/10.5306/wjco.v12.i11.1037

Ejemplares similares